Homework For Pharma As Chinese Payer Flexes Muscles
This article was originally published in PharmAsia News
Executive Summary
In a fast-changing, cost-control driven environment in China, pharma firms need to control their own costs, fortify their competitive edge via product value proposition, and help the payer, says one healthcare observer, amid mounting pressure on drug prices.